BackBecton Dickinson Overview

Becton Dickinson Total Current Liabilities

Track Becton Dickinson's total current liabilities ($8.5B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$8.51B
876.69% YoYΔ $7.64B vs prior year quarter

Peer average

Loading

Becton Dickinson Total Current Liabilities History

Loading

Becton Dickinson vs. peers: Total Current Liabilities Comparison

Loading

Becton Dickinson Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Becton Dickinson (BDX) FAQ

The latest total current liabilities for BDX is $8.5B as of March 2026. That compares with $870M in the prior-year period — up 876.7% year over year. Investors often review this figure alongside Becton Dickinson's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDX's total current liabilities moved from $870M to $8.5B — a 876.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Becton Dickinson's operating scale or balance-sheet position.

A total current liabilities figure of $8.5B for BDX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BDX's total current liabilities ($8.5B), review year-over-year change from $870M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Becton Dickinson's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.